Overview

Head Office
3-4-10, Shinsuna, Koto-ku, Tokyo
136-0075
Tel 03-5634-7006
Purposes
Research, development, manufacture, sale, purchase and import/export of radioactive pharmaceuticals, as well as radioactive medical devices and their related products
Incorporation
March 20,1973
Capital
3,145,780 thousand yen
Shareholders
Sumitomo Chemical Co., Ltd. 50%
GE Healthcare 50%
Customers
Major hospitals throughout Japan
Banks
Sumitomo Mitsui Banking Corporation
Sumitomo Mitsui Trust Bank, Limited
Sales
30.5 billion yen in the fiscal year 2020
Number of Employees
837(as of March 2021)
Affiliated Company
NMP Business Support Co., Ltd.[New window]

For inquiry

General Affairs Dept.
Tel 03-5634-7006
Research Centre
Tel 0438-62-7611

Management Line-up

(As of March 2021)

Representative Director President
Nobuhiko Tamura
Representative Director
(Non-executive)
Kevin O'Neill
DirectorExecutive Vice President
Yoshinori Wakatsuki
Director
(Non-executive)
Hiroshi Ueda
Director
(Non-executive)
Takashi Shigemori
Director
(Non-executive)
Takeo Kitayama
Director
(Non-executive)
Julia Casey
Director
(Non-executive)
Masaki Wakabayashi
Managing Executive Officer
Shizuto Shirota
Executive Officer
Yoshiharu Inuii
Executive Officer
Masahiro Takayama
Executive Officer
Shinichi Ota
Executive Officer
Nobuyuki Takahashi
Standing Corporate Auditor
Toshio Iguchi
Corporate Auditor
Hiroyuki Tanaka 
Corporate Auditor
Naoki Kobayashi